ALEX JAVARDIAN: Open Payments
NPI 1396222022 · COLLEGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,441 in 131 payments from 27 companies in 2025. Trend: 2023 $1,886 · 2024 $2,180 · 2025 $2,441
Food & beverage: $2,441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $328 |
| PFIZER INC. | 16 | $242 |
| Novo Nordisk Inc | 10 | $232 |
| Axsome Therapeutics, Inc. | 9 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $140 |
| Corcept Therapeutics | 4 | $130 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Gilead Sciences, Inc. | 3 | $93 |
Products named: VRAYLAR, REXULTI, NURTEC ODT, XIFAXAN, Korlym, UBRELVY, Wegovy, Symbravo.
Industry payments across PA — which companies pay providers there.
